title: Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients.
abstract: Hepatitis B virus (HBV) is one of the most common DNA viruses that can cause aggressive hepatitis, cirrhosis and hepatocellular carcinoma. Although many people are persistently infected with HBV, the kinetics in serum levels of viral loads and the host immune responses vary from person to person. HBV precore/core open reading frame (ORF) encoding proteins, hepatitis B e antigen (HBeAg) and core antigen (HBcAg), are two indicators of active viral replication. The aim of this study was to discover a variety of amino acid covariances in responses to viral kinetics, seroconversion and genotypes during the course of HBV infection. A one year follow-up study was conducted with a total number of 1,694 clones from 23 HBeAg-positive chronic hepatitis B patients. Serum alanine aminotransferase, HBV DNA and HBeAg levels were measured monthly as criteria for clustering patients into several different subgroups. Monthly derived multiple precore/core ORFs were directly sequenced and translated into amino acid sequences. For each subgroup, time-dependent covariances were identified from their time-varying sequences over the entire follow-up period. The fluctuating, wavering, HBeAg-nonseroconversion and genotype C subgroups showed greater degrees of covariances than the stationary, declining, HBeAg-seroconversion and genotype B. Referring to literature, mutation hotspots within our identified covariances were associated with the infection process. Remarkably, hotspots were predominant in genotype C. Moreover, covariances were also identified at early stage (spanning from baseline to a peak of serum HBV DNA) in order to determine the intersections with aforementioned time-dependent covariances. Preserved covariances, namely representative covariances, of each subgroup are visually presented using a tree-based structure. Our results suggested that identified covariances were strongly associated with viral kinetics, seroconversion and genotypes. Moreover, representative covariances may benefit clinicians to prescribe a suitable treatment for patients even if they have no obvious symptoms at the early stage of HBV infection.
authors.affiliation: Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.
authors.forename: Chun-Pei
authors.initials: CP
authors.lastname: Cheng
authors.forename: Pei-Fen
authors.initials: PF
authors.lastname: Lee
authors.forename: Wen-Chun
authors.initials: WC
authors.lastname: Liu
authors.forename: I-Chin
authors.initials: IC
authors.lastname: Wu
authors.forename: Chu-Yu
authors.initials: CY
authors.lastname: Chin
authors.forename: Ting-Tsung
authors.initials: TT
authors.lastname: Chang
authors.forename: Vincent S
authors.initials: VS
authors.lastname: Tseng
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000465:Algorithms; D004279:DNA, Viral / Q000235:genetics; D005260:Female; D005838:Genotype; D006509:Hepatitis B / Q000821:virology*; D006512:Hepatitis B Core Antigens / Q000737:chemistry / Q000235:genetics*; D006513:Hepatitis B e Antigens / Q000737:chemistry*; D006515:Hepatitis B virus / Q000737:chemistry*; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D016366:Open Reading Frames; D015203:Reproducibility of Results; D012306:Risk
chemical_list: D004279:DNA, Viral; D006512:Hepatitis B Core Antigens; D006513:Hepatitis B e Antigens; D000410:Alanine Transaminase